These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 239342)
61. The particulate superoxide-forming system from human neutrophils. Properties of the system and further evidence supporting its participation in the respiratory burst. Babior BM; Curnutte JT; McMurrich BJ J Clin Invest; 1976 Oct; 58(4):989-96. PubMed ID: 9426 [TBL] [Abstract][Full Text] [Related]
62. Generation of chemiluminescence by a particulate fraction isolated from human neutrophils. Analysis of molecular events. McPhail LC; DeChatelet LR; Johnston RB J Clin Invest; 1979 Apr; 63(4):648-55. PubMed ID: 35551 [TBL] [Abstract][Full Text] [Related]
63. Determinants of the production of active oxygen species by granulocytes and macrophages. Karnovsky ML; Badwey JA J Clin Chem Clin Biochem; 1983 Sep; 21(9):545-53. PubMed ID: 6313844 [TBL] [Abstract][Full Text] [Related]
64. Multiple leukocyte abnormalities in chronic granulomatous disease: a familial study. Rutenberg WD; Yang MC; Doberstyn EB; Bellanti JA Pediatr Res; 1977 Mar; 11(3 Pt 1):158-63. PubMed ID: 14326 [TBL] [Abstract][Full Text] [Related]
65. Autosomal recessive chronic granulomatous disease with absence of the 67-kD cytosolic NADPH oxidase component: identification of mutation and detection of carriers. de Boer M; Hilarius-Stokman PM; Hossle JP; Verhoeven AJ; Graf N; Kenney RT; Seger R; Roos D Blood; 1994 Jan; 83(2):531-6. PubMed ID: 8286749 [TBL] [Abstract][Full Text] [Related]
66. Point mutations in the promoter region of the CYBB gene leading to mild chronic granulomatous disease. Weening RS; De Boer M; Kuijpers TW; Neefjes VM; Hack WW; Roos D Clin Exp Immunol; 2000 Dec; 122(3):410-7. PubMed ID: 11122248 [TBL] [Abstract][Full Text] [Related]
67. Chronic granulomatous disease due to a defect in the cytosolic factor required for nicotinamide adenine dinucleotide phosphate oxidase activation. Curnutte JT; Berkow RL; Roberts RL; Shurin SB; Scott PJ J Clin Invest; 1988 Feb; 81(2):606-10. PubMed ID: 3339133 [TBL] [Abstract][Full Text] [Related]
68. [Description of a case of infantile chronic granulomatous disease on a granulocytopathic base]. Meroni R; D'Amico E Minerva Pediatr; 1977 May; 29(17):1135-40. PubMed ID: 875995 [No Abstract] [Full Text] [Related]
69. Abnormal bactericidal, metabolic, and lysosomal functions of Chediak-Higashi Syndrome leukocytes. Root RK; Rosenthal AS; Balestra DJ J Clin Invest; 1972 Mar; 51(3):649-65. PubMed ID: 4400956 [TBL] [Abstract][Full Text] [Related]
70. Subcellular localization and properties of the NAD(P)H oxidase from equine polymorphonuclear leukocytes. Heyneman RA Enzyme; 1983; 29(3):198-207. PubMed ID: 6303778 [TBL] [Abstract][Full Text] [Related]
71. Studies on the mechanism of metabolic stimulation in polymorphonuclear leucocytes during phagocytosis. I. Evidence for superoxide anion involvement in the oxidation of NADPH2. Patriarca P; Dri P; Kakinuma K; Tedesco F; Rossi F Biochim Biophys Acta; 1975 Apr; 385(2):380-6. PubMed ID: 236010 [TBL] [Abstract][Full Text] [Related]
72. The inducibility of TNF-alpha production is different in the granulocytic and monocytic differentiated forms of wild type and CGD-mutant PLB-985 cells. Selmeczy Z; Szelényi J; Német K; Vizi ES Immunol Cell Biol; 2003 Dec; 81(6):472-9. PubMed ID: 14636244 [TBL] [Abstract][Full Text] [Related]
73. Spectrum of function of neutrophils from carriers of sex-linked chronic granulomatous disease. Repine JE; Clawson CC; White JG; Holmes B J Pediatr; 1975 Dec; 87(6 Pt 1):901-7. PubMed ID: 1185391 [TBL] [Abstract][Full Text] [Related]
74. Delineation of the phagocyte NADPH oxidase through studies of chronic granulomatous diseases of childhood. Gallin JI; Leto TL; Rotrosen D; Kwong CH; Malech HL Curr Opin Immunol; 1992 Feb; 4(1):53-6. PubMed ID: 1317712 [TBL] [Abstract][Full Text] [Related]
75. Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system. Clark RA; Malech HL; Gallin JI; Nunoi H; Volpp BD; Pearson DW; Nauseef WM; Curnutte JT N Engl J Med; 1989 Sep; 321(10):647-52. PubMed ID: 2770793 [TBL] [Abstract][Full Text] [Related]
76. Cytosolic components of the respiratory burst oxidase: resolution of four components, two of which are missing in complementing types of chronic granulomatous disease. Curnutte JT; Scott PJ; Mayo LA Proc Natl Acad Sci U S A; 1989 Feb; 86(3):825-9. PubMed ID: 2915980 [TBL] [Abstract][Full Text] [Related]
77. Absence of cytochrome b-245 in chronic granulomatous disease. A multicenter European evaluation of its incidence and relevance. Segal AW; Cross AR; Garcia RC; Borregaard N; Valerius NH; Soothill JF; Jones OT N Engl J Med; 1983 Feb; 308(5):245-51. PubMed ID: 6848934 [TBL] [Abstract][Full Text] [Related]
78. Two X-linked chronic granulomatous disease patients with unusual NADPH oxidase properties. Wolach B; Broides A; Zeeli T; Gavrieli R; de Boer M; van Leeuwen K; Levy J; Roos D J Clin Immunol; 2011 Aug; 31(4):560-6. PubMed ID: 21604087 [TBL] [Abstract][Full Text] [Related]
79. Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay. Jirapongsananuruk O; Malech HL; Kuhns DB; Niemela JE; Brown MR; Anderson-Cohen M; Fleisher TA J Allergy Clin Immunol; 2003 Feb; 111(2):374-9. PubMed ID: 12589359 [TBL] [Abstract][Full Text] [Related]
80. Pyridine nucleotide-dependent generation of hydrogen peroxide by a particulate fraction from human neutrophils: effect of substrate concentration. DeChatelet LR; Shirley PS Inflammation; 1982 Sep; 6(3):217-26. PubMed ID: 7129596 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]